- Home
- PMCB vs SSY Comparison
PMCB vs SSY Comparison
Compare PMCB & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- SSY
- Stock Information
- Founded
- PMCB 1996
- SSY 1959
- Country
- PMCB United States
- SSY United States
- Employees
- PMCB N/A
- SSY N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- SSY Hospital/Nursing Management
- Sector
- PMCB Health Care
- SSY Health Care
- Exchange
- PMCB Nasdaq
- SSY Nasdaq
- Market Cap
- PMCB 7.3M
- SSY 6.2M
- IPO Year
- PMCB N/A
- SSY N/A
- Fundamental
- Price
- PMCB $1.11
- SSY $0.92
- Analyst Decision
- PMCB
- SSY
- Analyst Count
- PMCB 0
- SSY 0
- Target Price
- PMCB N/A
- SSY N/A
- AVG Volume (30 Days)
- PMCB 12.0K
- SSY 190.0K
- Earning Date
- PMCB 08-12-2025
- SSY 05-13-2025
- Dividend Yield
- PMCB N/A
- SSY N/A
- EPS Growth
- PMCB N/A
- SSY N/A
- EPS
- PMCB 1.29
- SSY 0.25
- Revenue
- PMCB N/A
- SSY $31,094,000.00
- Revenue This Year
- PMCB N/A
- SSY N/A
- Revenue Next Year
- PMCB N/A
- SSY N/A
- P/E Ratio
- PMCB $0.86
- SSY $3.53
- Revenue Growth
- PMCB N/A
- SSY N/A
- 52 Week Low
- PMCB $1.00
- SSY $0.62
- 52 Week High
- PMCB $2.42
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- PMCB 54.71
- SSY 42.58
- Support Level
- PMCB $1.00
- SSY $0.84
- Resistance Level
- PMCB $1.07
- SSY $1.06
- Average True Range (ATR)
- PMCB 0.05
- SSY 0.08
- MACD
- PMCB 0.01
- SSY -0.01
- Stochastic Oscillator
- PMCB 73.33
- SSY 13.64
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.